Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary Site

Study Title
Cost-effectiveness Study of miRviewג„¢ Mets in Patients With Cancer of Unknown Primary (CUP)
Teva Identifier
ONCO1miRviewmets
ClinicalTrials.gov Identifier
NCT01202786
Study Status
Completed
Trial Condition(s)
Neoplasms, Unknown Primary

Study Description

Please refer to ClinicalTrials.gov for a description of the trial



Key Participation Requirements

Gender
Female, Male
Age group
Adult, Older Adult
Age Range
18 Years and older
Trial Duration
05/01/2010 - 04/01/2012

Study Type

Observational